Early Cartilage Loss Predicts Knee Replacement
May 2, 2012|Family Practice News
Author and Disclosure Information
FROM THE WORLD CONGRESS ON OSTEOARTHRITIS
The meeting was sponsored by the Osteoarthritis Research Society International.
Dr. Eckstein reported ties with Medtronic, Merck Serono, Novartis, Perceptive, Pfizer, Sanofi-Aventis, and Synthes. He founded Chondrometrics in 2003. The study was funded by OAI, a public-private partnership of Novartis Pharma; the University of Pittsburgh’s Pivotal OAI MRI Analyses (POMA) study; the University of California, San Francisco; and the National Institutes of Health.
